No. According to the FDA, “There is no valid scientific data to demonstrate that thermography devices, when used on their own or with another diagnostic test, are an effective screening tool for any medical condition including the early detection of breast cancer or other diseases and health conditions .”
Thermography is a non-invasive technique that uses infrared technology to detect both heat and blood flow patterns very near the skin’s surface. Although some large cancers can be seen, these are usually palpable and so thermography adds little. Thermography has a high “false negative” rate (when a test result indicates “no cancer” – though cancer is actually present), especially for small breast cancers, so it does not play a role in screening asymptomatic women. Thermography also has a high rate of “indeterminate” findings, which on additional diagnostic evaluation (mammography, ultrasound, MRI, follow-up observation, etc.) indicate no cancer is found. These often prompt a recommendation for short interval follow-up, which creates anxiety and additional cost to the woman.
1. US Food and Drug Administration. FDA warns thermography should not be used in place of mammography to detect, diagnose, or screen for breast cancer: FDA Safety Communication. https://www.fda.gov/consumers/consumer-updates/breast-cancer-screening-thermogram-no-substitute-mammogram Published February 25, 2019. Accessed May 18, 2020